At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HIMS Hims & Hers Health Inc.
Pre-Mkt 07-30 05:27:20 EDT
25.00
-4.32
-14.73%
盘前24.95
-0.05-0.20%
05:25 EDT
High28.97Low24.73Vol29.24M
Open28.71D1 Closing29.32Amplitude14.46%
Mkt Cap5.78BTradable Cap5.26BTotal Shares231.07M
T/O764.41MT/O Rate13.88%Tradable Shares210.59M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

ETF Daily | IREZ, AAOZ Jump 27%; LMNX Plunges 48%; SOXS Rallies 16%; Inverse Index Funds Gain
ETF Tracker  ·  08:21
ETF Daily | IREZ, AAOZ Jump 27%; LMNX Plunges 48%; SOXS Rallies 16%; Inverse Index Funds Gain
Hims & Hers Rejects FTC Lawsuit, Vows to Fight Claims
Reuters  ·  01:51
Hims & Hers Rejects FTC Lawsuit, Vows to Fight Claims
US FTC Sues Hims & Hers for Sending User Health Info to Meta, Snap
Reuters  ·  01:43
US FTC Sues Hims & Hers for Sending User Health Info to Meta, Snap
Hims & Hers Stock Plunges After FTC Sues over Alleged Privacy Violations
Dow Jones  ·  01:34
Hims & Hers Stock Plunges After FTC Sues over Alleged Privacy Violations
Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading
MT Newswires Live  ·  01:33
Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading
Hims & Hers Says FTC Lawsuit Disregards Substantial Evidence We Provided the Agency During Investigation
Reuters  ·  01:18
Hims & Hers Says FTC Lawsuit Disregards Substantial Evidence We Provided the Agency During Investigation
Hims & Hers Health on FTC Lawsuit : We are Confident in Our Position and Will Vigorously Defend Ourselves Against These Baseless Claims
THOMSON REUTERS  ·  01:16
Hims & Hers Health on FTC Lawsuit : We are Confident in Our Position and Will Vigorously Defend Ourselves Against These Baseless Claims
Rpt: Hims & Hers on FTC Lawsuit: Lawsuit Disregards Substantial Evidence We Provided the FTC During Its Nearly Three-Year Investigation
THOMSON REUTERS  ·  01:16
Rpt: Hims & Hers on FTC Lawsuit: Lawsuit Disregards Substantial Evidence We Provided the FTC During Its Nearly Three-Year Investigation
FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports
MT Newswires Live  ·  00:47
FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports
Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap
THOMSON REUTERS  ·  00:44
Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap
US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap
Reuters  ·  00:30
US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap
Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says
THOMSON REUTERS  ·  00:30
Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says
Movement Alert｜Hims & Hers Health Inc. Falls 5.49% in Regular Trading, Trading at $27.69
Market Focus  ·  07-29 22:20
Movement Alert｜Hims & Hers Health Inc. Falls 5.49% in Regular Trading, Trading at $27.69
Hims & Hers Health (HIMS) Receives a Hold from Truist Financial
TIPRANKS  ·  07-29 10:26
Hims & Hers Health (HIMS) Receives a Hold from Truist Financial
Movement Alert｜Hims & Hers Health Inc. Falls 5.59% in Regular Trading, Trading at $27.83
Market Focus  ·  07-28 22:42
Movement Alert｜Hims & Hers Health Inc. Falls 5.59% in Regular Trading, Trading at $27.83
Movement Alert｜Hims & Hers Health Inc. Rises 5.5% in Regular Trading, FDA Advisory Committee Supports Bpc-157 Peptide Compounding Approval
Market Focus  ·  07-27 21:55
Movement Alert｜Hims & Hers Health Inc. Rises 5.5% in Regular Trading, FDA Advisory Committee Supports Bpc-157 Peptide Compounding Approval
Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?
TIPRANKS  ·  07-25
Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?
Hims & Hers falls -10.3%
TIPRANKS  ·  07-25
Hims & Hers falls -10.3%
U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor
Reuters  ·  07-24
U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor
Movement Alert｜Hims & Hers Health Inc. Rises 5.04% in Regular Trading, FDA Advisory Committee Backs Bpc-157 Peptide for Pharmacy Compounding
Market Focus  ·  07-24
Movement Alert｜Hims & Hers Health Inc. Rises 5.04% in Regular Trading, FDA Advisory Committee Backs Bpc-157 Peptide for Pharmacy Compounding

Introduction

Company Name.
Hims & Hers Health Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Issue price:
--